Moomoo AI 已提取核心信息
Illumina, Inc., a leading company in the genomics industry, filed a Form 8-K with the U.S. Securities and Exchange Commission on January 4, 2024. The report announced the departure of Susan Tousi, the Chief Commercial Officer of Illumina, effective January 5, 2024. Following Tousi's departure, Bas Verhoef, currently Head of Region – Europe, will assume the role of Interim Chief Commercial Officer. The company's common stock is registered under the trading symbol ILMN on the NASDAQ. This executive change comes as part of the company's ongoing management adjustments and has been officially documented in the report signed by Charles E. Dadswell, General Counsel and Secretary of Illumina, Inc.
Illumina, Inc., a leading company in the genomics industry, filed a Form 8-K with the U.S. Securities and Exchange Commission on January 4, 2024. The report announced the departure of Susan Tousi, the Chief Commercial Officer of Illumina, effective January 5, 2024. Following Tousi's departure, Bas Verhoef, currently Head of Region – Europe, will assume the role of Interim Chief Commercial Officer. The company's common stock is registered under the trading symbol ILMN on the NASDAQ. This executive change comes as part of the company's ongoing management adjustments and has been officially documented in the report signed by Charles E. Dadswell, General Counsel and Secretary of Illumina, Inc.
基因组学行业的领先公司Illumina, Inc. 于2024年1月4日向美国证券交易委员会提交了8-K表格。该报告宣布，Illumina首席商务官苏珊·图西自2024年1月5日起离职。图西离职后，现任欧洲地区负责人Bas Verhoef将担任临时首席商务官一职。该公司的普通股在纳斯达克注册的交易代码为ILMN。此次高管变动是公司正在进行的管理调整的一部分，并已正式记录在Illumina, Inc.总法律顾问兼秘书查尔斯·达德斯韦尔签署的报告中。
基因组学行业的领先公司Illumina, Inc. 于2024年1月4日向美国证券交易委员会提交了8-K表格。该报告宣布，Illumina首席商务官苏珊·图西自2024年1月5日起离职。图西离职后，现任欧洲地区负责人Bas Verhoef将担任临时首席商务官一职。该公司的普通股在纳斯达克注册的交易代码为ILMN。此次高管变动是公司正在进行的管理调整的一部分，并已正式记录在Illumina, Inc.总法律顾问兼秘书查尔斯·达德斯韦尔签署的报告中。
有用
没用